Lineage-specific events underlie aortic root aneurysm pathogenesis in Loeys-Dietz syndrome

The aortic root is the predominant site for development of aneurysm caused by heterozygous loss-of-function mutations in positive effectors of the transforming growth factor-&bgr; (TGF-&bgr;) pathway. Using a mouse model of Loeys-Dietz syndrome (LDS) that carries a heterozygous kinase-inactivating mutation in TGF-&bgr; receptor I, we found that the effects of this mutation depend on the lineage of origin of vascular smooth muscle cells (VSMCs). Secondary heart field–derived (SHF-derived), but not neighboring cardiac neural crest–derived (CNC-derived), VSMCs showed impaired Smad2/3 activation in response to TGF-&bgr;, increased expression of angiotensin II (AngII) type 1 receptor (Agtr1a), enhanced responsiveness to AngII, and higher expression of TGF-&bgr; ligands. The preserved TGF-&bgr; signaling potential in CNC-derived VSMCs associated, in vivo, with increased Smad2/3 phosphorylation. CNC-, but not SHF-specific, deletion of Smad2 preserved aortic wall architecture and reduced aortic dilation in this mouse model of LDS. Taken together, these data suggest that aortic root aneurysm predisposition in this LDS mouse model depends both on defective Smad signaling in SHF-derived VSMCs and excessive Smad signaling in CNC-derived VSMCs. This work highlights the importance of considering the regional microenvironment and specifically lineage-dependent variation in the vulnerability to mutations in the development and testing of pathogenic models for aortic aneurysm.

[1]  S. Mehta,et al.  A mutation update on the LDS‐associated genes TGFB2/3 and SMAD2/3 , 2018, Human mutation.

[2]  G. Lembo,et al.  Targeting Interleukin‐1&bgr; Protects from Aortic Aneurysms Induced by Disrupted Transforming Growth Factor &bgr; Signaling , 2017, Immunity.

[3]  R. Derynck,et al.  Transforming Growth Factor-b Receptors and Smads : Regulatory Complexity and Functional Versatility , 2017 .

[4]  N. Hibino,et al.  Aortic Root Replacement for Children With Loeys-Dietz Syndrome. , 2017, The Annals of thoracic surgery.

[5]  D. Dichek,et al.  What's the Skinny on Elastin Deficiency and Supravalvular Aortic Stenosis? , 2017, Arteriosclerosis, Thrombosis and Vascular Biology.

[6]  B. Loeys,et al.  Aetiology and management of hereditary aortopathy , 2017, Nature Reviews Cardiology.

[7]  Ying E Zhang,et al.  Non-Smad Signaling Pathways of the TGF-β Family. , 2017, Cold Spring Harbor perspectives in biology.

[8]  D. Milewicz,et al.  Therapeutics Targeting Drivers of Thoracic Aortic Aneurysms and Acute Aortic Dissections: Insights from Predisposing Genes and Mouse Models. , 2017, Annual review of medicine.

[9]  D. Dichek,et al.  Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling , 2017, Journal of the American Heart Association.

[10]  A. Daugherty,et al.  Transforming Growth Factor‐β in Thoracic Aortic Aneurysms: Good, Bad, or Irrelevant? , 2017, Journal of the American Heart Association.

[11]  F. Schoenhoff.  Increased TGF-β Signaling Precedes Aneurysm Formation in SMAD3 Deficient Mice , 2016, EBioMedicine.

[12]  G. Mortier,et al.  Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections , 2016, Genetics in Medicine.

[13]  R. Kanaar,et al.  Defective Connective Tissue Remodeling in Smad3 Mice Leads to Accelerated Aneurysmal Growth Through Disturbed Downstream TGF-β Signaling , 2016, EBioMedicine.

[14]  A. Hata,et al.  TGF-β Signaling from Receptors to Smads. , 2016, Cold Spring Harbor perspectives in biology.

[15]  J. Humphrey,et al.  Differential ascending and descending aortic mechanics parallel aneurysmal propensity in a mouse model of Marfan syndrome. , 2016, Journal of biomechanics.

[16]  C. Heldin,et al.  Signaling Receptors for TGF-β Family Members. , 2016, Cold Spring Harbor Perspectives in Biology.

[17]  E. Isselbacher,et al.  Hereditary Influence in Thoracic Aortic Aneurysm and Dissection. , 2016, Circulation.

[18]  D. Rifkin,et al.  Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins. , 2016, Cold Spring Harbor perspectives in biology.

[19]  D. Iyer,et al.  Embryological Origin of Human Smooth Muscle Cells Influences Their Ability to Support Endothelial Network Formation , 2016, Stem cells translational medicine.

[20]  A. Daugherty,et al.  TGF-β Neutralization Enhances AngII-Induced Aortic Rupture and Aneurysm in Both Thoracic and Abdominal Regions , 2016, PloS one.

[21]  J. Essers,et al.  AT1-receptor blockade, but not renin inhibition, reduces aneurysm growth and cardiac failure in fibulin-4 mice , 2016, Journal of hypertension.

[22]  G. Vriend,et al.  SMAD2 Mutations Are Associated with Arterial Aneurysms and Dissections , 2015, Human mutation.

[23]  D. Dichek,et al.  Postnatal Deletion of the Type II Transforming Growth Factor-&bgr; Receptor in Smooth Muscle Cells Causes Severe Aortopathy in Mice , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[24]  J. Humphrey,et al.  Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections. , 2015, Circulation research.

[25]  B. Wentworth,et al.  Dimorphic Effects of Transforming Growth Factor-&bgr; Signaling During Aortic Aneurysm Progression in Mice Suggest a Combinatorial Therapy for Marfan Syndrome , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[26]  M. Goumans,et al.  Mutations in a TGF-β Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and Dissections , 2015, Journal of the American College of Cardiology.

[27]  B. Alman,et al.  Prestress in the extracellular matrix sensitizes latent TGF-β1 for activation , 2014, The Journal of cell biology.

[28]  K. Eagle,et al.  Thoracic aortic aneurysm and dissection. , 2014, Journal of the American College of Cardiology.

[29]  Jie Zhu,et al.  Inhibin at 90: from discovery to clinical application, a historical review. , 2014, Endocrine reviews.

[30]  H. Dietz,et al.  Loeys–Dietz syndrome: a primer for diagnosis and management , 2014, Genetics in Medicine.

[31]  J. Humphrey,et al.  Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. , 2014, The Journal of clinical investigation.

[32]  D. Iyer,et al.  Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application , 2014, Cellular and Molecular Life Sciences.

[33]  Sarah J. Parker,et al.  Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. , 2014, The Journal of clinical investigation.

[34]  Henk A Marquering,et al.  Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. , 2013, European heart journal.

[35]  Philippe Soriano,et al.  The widely used Wnt1-Cre transgene causes developmental phenotypes by ectopic activation of Wnt signaling. , 2013, Developmental biology.

[36]  P. Blanke,et al.  Late complications and distal growth rates of Marfan aortas after proximal aortic repair. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[37]  E. Bottinger,et al.  Smad2 and Myocardin-Related Transcription Factor B Cooperatively Regulate Vascular Smooth Muscle Differentiation From Neural Crest Cells , 2013, Circulation research.

[38]  M. Majesky,et al.  Interpreting inflammation: smooth muscle positional identity and nuclear factor-κB signaling. , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[39]  A. Dopazo,et al.  Embryological-Origin–Dependent Differences in Homeobox Expression in Adult Aorta: Role in Regional Phenotypic Variability and Regulation of NF-&kgr;B Activity , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[40]  Paul Coucke,et al.  Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAAD. , 2013, International journal of cardiology.

[41]  L. Garavelli,et al.  Thoracic Aortic Aneurysm in Infancy in Aneurysms–Osteoarthritis Syndrome Due to a Novel SMAD3 Mutation: Further Delineation of the Phenotype , 2013, American journal of medical genetics. Part A.

[42]  P. Zhang,et al.  GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency. , 2013, The Journal of clinical investigation.

[43]  A. Daugherty,et al.  Conundrum of angiotensin II and TGF-β interactions in aortic aneurysms. , 2013, Current opinion in pharmacology.

[44]  P. Robinson,et al.  In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome. , 2012, American journal of human genetics.

[45]  Seneca L. Bessling,et al.  Mutations in the TGF-β Repressor SKI Cause Shprintzen-Goldberg Syndrome with Aortic Aneurysm , 2012, Nature Genetics.

[46]  E. Fishman,et al.  Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm , 2012, Nature Genetics.

[47]  M. Trotter,et al.  Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility , 2012, Nature Biotechnology.

[48]  B. Hinz,et al.  The Single-Molecule Mechanics of the Latent TGF-β1 Complex , 2011, Current Biology.

[49]  J. Elefteriades,et al.  Contemporary Reviews in Cardiovascular Medicine Medical Therapy of Thoracic Aortic Aneurysms , 2011 .

[50]  D. Kass,et al.  Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload. , 2011, The Journal of clinical investigation.

[51]  H. Dietz,et al.  Lessons on the pathogenesis of aneurysm from heritable conditions , 2011, Nature.

[52]  D. Judge,et al.  Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism , 2011, Science.

[53]  Samarjit Patnaik,et al.  Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice , 2011, Science.

[54]  A. Hinck,et al.  TGF‐β signalling is mediated by two autonomously functioning TβRI:TβRII pairs , 2011, The EMBO journal.

[55]  G. Vriend,et al.  Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis , 2011, Nature Genetics.

[56]  G. Karsenty,et al.  Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation , 2010, The Journal of cell biology.

[57]  J. Michel,et al.  Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms , 2010, Cardiovascular research.

[58]  F. Ramirez,et al.  Extracellular regulation of transforming growth factor β and bone morphogenetic protein signaling in bone , 2010, Annals of the New York Academy of Sciences.

[59]  Madhusudhan Budatha,et al.  Fibulin-4 Deficiency Results in Ascending Aortic Aneurysms: A Potential Link Between Abnormal Smooth Muscle Cell Phenotype and Aneurysm Progression , 2010, Circulation research.

[60]  L. Rénia,et al.  TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. , 2010, The Journal of clinical investigation.

[61]  Allan R. Jones,et al.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.

[62]  A. Al Haj Zen,et al.  Syndromic and non‐syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway , 2009, The Journal of pathology.

[63]  V. Kaartinen,et al.  Absence of TGFβ signaling in embryonic vascular smooth muscle leads to reduced lysyl oxidase expression, impaired elastogenesis, and aneurysm , 2009, Genesis.

[64]  T. Gudermann,et al.  Gq‐coupled receptors as mechanosensors mediating myogenic vasoconstriction , 2008, EMBO Journal.

[65]  A. Mercurio.  Faculty Opinions recommendation of Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. , 2007 .

[66]  Jing Qing,et al.  TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA , 2007 .

[67]  D. Judge,et al.  Loss of Elastic Fiber Integrity and Reduction of Vascular Smooth Muscle Contraction Resulting From the Upregulated Activities of Matrix Metalloproteinase-2 and -9 in the Thoracic Aortic Aneurysm in Marfan Syndrome , 2007, Circulation research.

[68]  Samy Lamouille,et al.  Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway , 2007, The Journal of cell biology.

[69]  P. Byers,et al.  Aneurysm syndromes caused by mutations in the TGF-beta receptor. , 2006, The New England journal of medicine.

[70]  George H. Thomas,et al.  Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .

[71]  Marc K. Halushka,et al.  Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.

[72]  R. Kucherlapati,et al.  Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation , 2006, Molecular and Cellular Biology.

[73]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[74]  Raquel P. Ritchie,et al.  Myocardin Enhances Smad3-Mediated Transforming Growth Factor-β1 Signaling in a CArG Box-Independent Manner: Smad-Binding Element Is an Important cis Element for SM22α Transcription In Vivo , 2005, Circulation research.

[75]  M. Buckingham,et al.  Building the mammalian heart from two sources of myocardial cells , 2005, Nature Reviews Genetics.

[76]  E. Dodou,et al.  The right ventricle, outflow tract, and ventricular septum comprise a restricted expression domain within the secondary/anterior heart field. , 2005, Developmental biology.

[77]  S. Kudoh,et al.  Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II , 2004, Nature Cell Biology.

[78]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[79]  D. Arking,et al.  Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome , 2003, Nature Genetics.

[80]  R. Lechleider,et al.  Smad proteins regulate transcriptional induction of the SM22α gene by TGF‐β , 2003 .

[81]  D. Chitayat,et al.  Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome. , 2002, American journal of human genetics.

[82]  Shankar Srinivas,et al.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus , 2001, BMC Developmental Biology.

[83]  S Eguchi,et al.  Activation of MAPKs by Angiotensin II in Vascular Smooth Muscle Cells , 2001, The Journal of Biological Chemistry.

[84]  A. McMahon,et al.  Fate of the mammalian cardiac neural crest. , 2000, Development.

[85]  R. Mecham,et al.  Novel arterial pathology in mice and humans hemizygous for elastin. , 1998, The Journal of clinical investigation.

[86]  M. Kowala,et al.  Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo. , 1997, Journal of Clinical Investigation.

[87]  S. Topouzis,et al.  Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta. , 1996, Developmental biology.

[88]  G. Gibbons,et al.  Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. , 1992, The Journal of clinical investigation.

[89]  Mark W Majesky,et al.  Smooth Muscle Cells Derived From Second Heart Field and Cardiac Neural Crest Reside in Spatially Distinct Domains in the Media of the Ascending Aorta—Brief Report , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[90]  M. Nataatmadja,et al.  Angiotensin II Receptor Antagonism Reduces Transforming Growth Factor Beta and Smad Signaling in Thoracic Aortic Aneurysm. , 2013, The Ochsner journal.

[91]  Gallo,et al.  Loss-of-function mutations in TGFB 2 cause a syndromic presentation of thoracic aortic aneurysm , 2013 .

[92]  M. Buckingham,et al.  How to make a heart: the origin and regulation of cardiac progenitor cells. , 2010, Current Topics in Developmental Biology.

[93]  Jing Qing,et al.  TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. , 2007, The EMBO journal.

[94]  Raquel P. Ritchie,et al.  Myocardin Enhances Smad 3-Mediated Transforming Growth Factor-1 Signaling in a CArG Box – Independent Manner Smad-Binding Element Is an Important cis Element for SM 22 Transcription In Vivo , 2005 .

[95]  R. Derynck,et al.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.

[96]  D. Arking,et al.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. , 2003, Nature genetics.

[97]  R. Lechleider,et al.  Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta. , 2003, Nucleic acids research.

[98]  Topouzis,et al.  Smooth Muscle Lineage Diversity in the Chick Embryo , 1996, Developmental Biology.